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Abstract: Candida albicans is an opportunistic fungal pathogen that infects immunocompromised
patients. Infection control requires phagocytosis by innate immune cells, including macrophages.
Migration towards, and subsequent recognition of, C. albicans fungal cell wall components by
macrophages is critical for phagocytosis. Using live-cell imaging of phagocytosis, the macrophage
cell line J774.1 showed enhanced movement in response to C. albicans cell wall mutants, particularly
during the first 30 min, irrespective of the infection ratio. However, phagocyte migration was
reduced up to 2-fold within a C. albicans biofilm compared to planktonic fungal cells. Biofilms
formed from C. albicans glycosylation mutant cells also inhibited macrophage migration to a similar
extent as wildtype Candida biofilms, suggesting that the physical structure of the biofilm, rather
than polysaccharide matrix composition, may hamper phagocyte migration. These data illustrate
differential macrophage migratory capacities, dependent upon the form of C. albicans encountered.
Impaired migration of macrophages within a C. albicans biofilm may contribute to the recalcitrant
nature of clinical infections in which biofilm formation occurs.
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1. Introduction
Human mucosal surfaces are frequently colonised by Candida albicans, although host surveillance
by host innate defense normally prevents the transition from commensal colonisation to infection [1].
Protection against candidiasis relies mainly upon professional phagocytes, including neutrophils
and macrophages, whose phagocytic uptake and degradation of the target microbe are critical to the
inactivation of fungal particles [2]. C. albicans is a constituent of the commensal microflora, but can
overgrow in the absence of normal control measures, including intact epithelial barriers, a competitive
bacterial microbiota, and normal immune function. Fungal growth can occur within a diverse range of
host compartments with varying pH and nutrient availabilities, to which this species readily adapts,
resulting in multiple C. albicans morphologies that are differentially recognised by immune surveillance
mechanisms [3–6]. In addition, fungal pathogens can alter and manipulate the environment in which
they are growing by creating a biofilm.
Individual yeast cells can initiate biofilm formation on the surfaces of medical and prosthetic
devices. C. albicans biofilms are characterised primarily by a supporting layer of yeast cells, from
which filamentous hyphae and pseudohyphae are formed, and the secretion of extracellular material
containing significant amounts of β-glucan and DNA [7]. Candida biofilms are recalcitrant to antifungal
therapy, and can cause prosthetic devices to fail through biofouling of mechanisms. They also resist
host immune defenses, and are a reservoir from which subsequent infections are disseminated [8].
The mortality rate for blood stream infections of Candida is elevated when biofilms form efficiently [9].
The response of immune cells to fungal biofilms has been the subject of little investigation,
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yet interactions between phagocytes and C. albicans will have a profound influence on the outcome of
a fungal infection [2].
We have previously investigated the phagocytic interactions of individual C. albicans cells using
live cell imaging and analysis methods, including tracking the individual migratory pathways of host
cells [10–12]. This study compares real time interactions between host and pathogen to determine
how the fungus C. albicans influences the migration activity of macrophages responding to individual
fungal particles or 3D biofilm structures, thereby representing different fungal growth forms that
may be encountered in the host. Phagocyte migration (mean track velocity) increased in response to
individual C. albicans cells displaying altered cell wall architecture, confirming previous findings [10].
Cell wall mutants were selected that represent defects in O-mannosylation, N-mannosylation, O-
and N-mannosylation, and phoshomannan (Table 1). Macrophage migration kinetics were markedly
impaired (up to 2-fold) in a fungal biofilm, underlining that biofilms not only impair chemotherapeutic
treatments, but also the effectiveness of the innate immune response. The approach used here offers
valuable insight into the physical responses of professional phagocytes, within the clinically relevant
context of 3D biofilms, at the host–pathogen interface.
Table 1. Strains of C. albicans used in this study.
Strain Name Strain Number Disrupted Target Phenotype Reference
CAI4-CIp10 NGY152 Not applicable (n/a) Wild type [13]
mnt1∆/mnt2∆ NGY111 α-(1,2)-mannosyltransferases O-mannan defect [14]
mnt1∆/mnt2∆+MNT1 NGY335 n/a Complemented mutant [14]
pmr1∆ NGY355 P-type Ca
2+/Mns2+-
ATPase
N-linked mannan and O-linked
mannan and phosphomannan defect [15]
pmr1∆+PMR1 NGY356 n/a Complemented mutant [15]
mns1∆ HMY5 α-(1,2)-mannosidase Terminal stage N-linked coremannan defect [16]
mnn4∆ CDH15 mannosylphosphatetransferase Phosphomannan incorporation defect [17]
2. Materials and Methods
2.1. C. albicans Strains and Growth Conditions
Glycosylation mutants used in this study (Table 1) were previously constructed in the
C. albicans CAI4 serotype A background by targeted gene disruption, using URA3 as a selectable
marker [18]. A double mutant, the mnt1∆mnt2∆ O-glycosylation mutant, was studied rather than
individual mutants of MNT1 or MNT2, as there is some degree of redundancy in the encoded
mannosyltransferases [14]. A control strain was used in which a single reintegrated copy of the
deleted MNT1 gene was re-introduced, which regenerated the heterozygous genotype and restored
O-mannosylation of cell wall proteins [14]. This served as an additional control, alongside the parental
strain CAI4. All strains had been transformed with the integrating vector CIp10 to control for uniform
expression of URA3 [19] as to confer isogenic Ura status. C. albicans strains from glycerol stocks stored
at −80 ◦C were grown in SC-Ura medium (6.9 g yeast nitrogen base without amino acids (Formedium,
Norfolk, UK), 1 mL 1 M NaOH (BDH Chemicals, VWR International, Leicestershire, UK), 10 mL
1% (w/v) adenine hemisulphate salt (Sigma, Dorset, UK), 50 mL 40% D-glucose (Fisher Scientific,
Leicestershire, UK), and 50 mL 4% SC-Ura dropout (Formedium), and were made up to 1000 mL in
distilled H2O, with or without 2% (w/v) technical agar (Oxoid, Cambridge, UK)). Plates were incubated
at 30 ◦C for 48 h and then stored at 5 ◦C. Liquid cultures were grown with continuous shaking at
200 rpm, at 30 ◦C. Biofilms were prepared by seeding µ-Slide 8-well chambers (ibidi GmbH, Munich,
Germany) with 3 × 105 Leicestershire live C. albicans yeast in Dulbecco’s Modified Eagle Medium
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(DMEM; Lonza, Slough, UK), supplemented with 10% (v/v) heat-inactivated FCS (Biosera, Ringmer,
UK), 200 U/mL penicillin/streptomycin antibiotics (Invitrogen, Paisley, UK), and 2 mM L-glutamine
(Invitrogen, Paisley, UK), at 37 ◦C for 48 h. There were two assay designs, with planktonic yeast added
to either imaging dishes containing macrophages, or to fungal biofilms with macrophages added in.
2.2. Preparation of J774.1 Murine Macrophage Cell Line
J774.1 macrophages (ECACC, HPA, Salisbury, UK) were retrieved from stocks stored in liquid
nitrogen. Cells were maintained in tissue culture flasks, in supplemented DMEM medium, at 37 ◦C,
with 5% CO2. For phagocytosis assays, 1 × 105 J774.1 macrophages, in 300 µL supplemented DMEM
medium, were seeded onto µ-Slide 8-well chambers, and cultured overnight at 37 ◦C, with 5% CO2.
2.3. Macrophage Migration Assays
Live phagocytosis assays were prepared as described in earlier work [10–12,20,21]. Single C. albicans
colonies from plates were cultured overnight in 5 mL SC-Ura medium as described above. On the day
of the experiment, cells were harvested by centrifugation (6000 rpm, 1 min), washed three times with
1 mL phosphate buffered saline (PBS), resuspended in 1 mL PBS, and quantified using an Improved
Neubauer haemocytometer chamber. Live imaging assays were conducted with 3 × 105 yeast cells,
combined with 1 × 105 J774.1 macrophages, in supplemented DMEM, within µ-Slide 8-well chambers.
Wells with fresh supplemented DMEM, but without fungi, were used as controls. Imaging was
performed using an UltraVIEW VoX 3D spinning disk confocal microscope, using a 20× or 40×
objective with Volocity 6.3 software (PerkinElmer, Cambridge, UK), and an environmental control
chamber set at 37 ◦C, and 5% CO2. Images were captured using multipoint acquisition at 90 s intervals
for 1 h, following a 15 min period to set up the microscope, and allow C. albicans cells to descend
towards adherent macrophages. For some experiments, the multiplicity of infection (MOI) was changed
so that 1 × 105, 3 × 105, or 10 × 105 yeast cells were added to 1 × 105 J774.1 macrophages in µ-Slide
8-well chambers immediately prior to imaging. Prior to biofilm 3D microscopy, fungal cell walls were
stained with 5 µg·mL−1 Calcoflour White (CFW), and macrophages were stained with LysoTracker Red
DND-99 (ThermoFisher), at a dilution of 1:1000 for 10 min prior to washing with DMEM. Macrophages
were resuspended by gentle scraping, then washed and counted. Samples of 1 × 105 macrophages
were added to each well for biofilm and planktonic cell experiments. Three-dimensional imaging
was conducted at 2 min intervals, using 561 and 405 laser lines to collect z-stacks of 60 µm thickness
imaged at 1 µm intervals, following a 45 min period prior to image acquisition, to set up the imaging
parameters and to allow for macrophages to descend.
2.4. Analysis of Live Cell Microscopy Movies
Volocity imaging and analysis software was used to analyse the live cell movies obtained.
Three independent experiments were conducted for each condition, and within each experiment,
duplicates were conducted for all conditions. 50 or 25 macrophages were randomly selected from each
experimental condition (cell wall mutant or MOI migration, respectively), and were manually tracked
at 90 s intervals for 1 h. Manual tracking of the migration process towards fungal particles allowed the
construction of macrophage tracking diagrams, illustrating the distance travelled, directionality, and
velocity, for each individual macrophage tracked. Quantitative migration data were analysed in 10 min
bins to evaluate whether macrophage migration exhibited temporal variation over the time course.
For 3D imaging, analysis of tracking at 2 min intervals was performed for the first 30 min of z-stack
acquisition, beyond which photo-bleaching and toxicity were deemed to be potentially compromising.
Mean velocities for each experimental condition were calculated and presented as values relative to
the velocity of macrophages in wells with no Candida, or relative to relevant planktonic controls for
biofilm experiments.
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2.5. Statistical Analyses
Mean values and standard deviations were calculated. Statistical significance was determined by
two-way analysis of variance (ANOVA), the categories being biological replicate and fungal strain,
with Bonferroni Multiple Analysis Comparison Tests, or by one-way ANOVA and Tukey Multiple
Analysis Comparison Tests. For comparisons of two groups, Student’s t-test was performed.
3. Results
3.1. Macrophage Migration towards C. albicans Is Not Altered by Multiplicity of Infection
We first characterised in detail the macrophage response to live C. albicans. Live cell video
microscopy (a representative movie can be viewed: supplementary Video 1) combined with image
analysis tools allowed tracking of individual cells. Representative images showing the tracking process
of a single macrophage migrating towards, and finally engulfing, a C. albicans yeast cell are shown in
Figure S1. Macrophages exhibited some degree of random movement, but were capable of directing
their movement towards the C. albicans yeast cell target. J774.1 macrophages were exposed to live yeast
C. albicans for up to 60 min, and time lapse captured at 90 s intervals. To elucidate macrophage migration
dynamics towards increasing quantities of C. albicans cells, experiments were carried out using different
MOI ratios (1:1, 3:1 and 10:1) of control strain CAI4. Tracking diagrams did not reveal any major
differences between experiments carried out at these MOI ratios (not shown). Quantitative analysis
revealed that no significant difference in migratory activity was observed between the experiments
using the different MOI ratios throughout the 1 h observation period (Figure 1). Migration speed was
greatest at earlier stages of the experiment and gradually decreased over time (Figure 1).
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migration towards the glycosylation mutants when compared to wild type macrophages (Figure S2). 
For every strain used in this study, migration was greater at the earlier stages of the experiment and 
gradually decreased over time (Figure 2). Macrophage migration was enhanced towards the 
mnt1Δmnt2Δ strain (1.45 ± 0.03 SD, p < 0.05, 50 macrophages, n = 3) when compared to the wildtype 
CAI4 strain (1.33 ± 0.04 SD after 1 h tracking). Elevated migration was observed throughout all 10 
min intervals within the 1 h observation period, but was most pronounced during the first 20 min of 
Figure 1. Quantitative analysis of macrophage migration in the presence of different multiplicity of
infection (MOI) ratios of wildtype C. albicans. The chart shows mean relative macrophage velocity
(relative to macrophage velocity without Candida) + SD of J774.1 macrophages when cultured with 1:1,
3:1 and 10:1 C. albicans ratios. Statistical significance was evaluated using two-way analysis of variance
(ANOVA) and Bonferroni Multiple Analysis Comparison Tests. No statistically significant difference
was observed in 25 macrophages analysed from independent experiments (n = 3).
3.2. Macrophage Migration Dynamics towards C. albicans Is Affected by Fungal Cell Wall Composition
Previous studies have shown that C. albicans phagocytosis by macrophages was altered by fungal
cell wall composition [22]; however, the extent to which different stages of the phagocytic process
(migration, recognition, engulfment, digestion) contributed to the observed overall effect is not known.
J774.1 macrophages were exposed to four glycosylation defective C. albicans strains (mnt1∆mnt2∆,
pmr1∆, mns1∆, and mnn4∆ (Table 1)), all of which have previously been shown to be phagocytosed
differentially [22]. Migration track diagrams suggested enhanced macrophage migration towards the
glycosylation mutants when compared to wild type macrophages (Figure S2). For every strain used in
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this study, migration was greater at the earlier stages of the experiment and gradually decreased over
time (Figure 2). Macrophage migration was enhanced towards the mnt1∆mnt2∆ strain (1.45 ± 0.03 SD,
p < 0.05, 50 macrophages, n = 3) when compared to the wildtype CAI4 strain (1.33 ± 0.04 SD after 1 h
tracking). Elevated migration was observed throughout all 10 min intervals within the 1 h observation
period, but was most pronounced during the first 20 min of the experiment (CAI4 1.53 ± 0.17 SD;
mnt1∆mnt2∆ 1.69 ± 10.2 SD, p < 0.001; Figure 2a). No significant difference was observed for a strain
functionally restored with a copy of MNT1 mnt1∆mnt2∆+MNT1 (1.37 ± 0.02 SD, 1 h) when compared
to CAI4 (Figure 2a).
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3.3. Macrophage Migration is Diminished within a 3D C. albicans Biofilm 
Having established that a kinetic response is elicited from adherent macrophages in response to 
individual planktonic C. albicans, we next assessed phagocyte migration in response to C. albicans that 
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Figure 2. Quantitative analysis of macrophage migration towards wildtype and glycosylation C. albicans
mutants. The charts show mean relative macrophage velocity (relative to macrophage velocity
without Candida) + SD of J774.1 macrophages when cultured with: (a) CAI4, mnt1∆ mnt2∆, and
mnt1∆ mnt2∆+MNT1; and (b) CAI4, pmr1∆, mns1∆, and mnn4∆ at 10 min intervals during the 1 h
observation period. Statistical significance was evaluated using two-way analysis of variance (ANOVA)
and Bonferroni Multiple Analysis Comparison Tests. * p < 0.05; ** p < 0.01; *** p < 0.001; 50 macrophages
analysed from independent experiments (n = 3). All of the values were significantly different from the
normalised average velocity.
For the other cell wall mutants assayed in this study, quantitative analysis showed no
significant differences in migration towards these strains when compared to wildtype, except for
mns1∆ (CAI4 1.39 ± 0.12 SD; mns1∆ 1.62 ± 0.28 SD; p < 0.05; Figure 2b). Nonetheless, the same trend
observed for mnt1∆mnt2∆ was identified here, with the mutants consistently exhibiting higher relative
velocities than wildtype (e.g., CAI4 1.28 ± 0.06 SD, pmr1∆ 1.35 ± 0.06 SD, mns1∆ 1.44 ± 0.07 SD, and
mnn4∆ 1.37 ± 0.15 SD, 1 h) (Figure 2b). The differences seen in migration assays for the C. albicans
glycosylation mutants did not appear to be a consequence of increased maximum macrophage velocity
(Figure S3), but a result of increased overall macrophage activity. Therefore, the glycosylation status of
the target yeast cell wall had a significant effect on the migration of the macrophage towards it.
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3.3. Macrophage Migration is Diminished within a 3D C. albicans Biofilm
Having established that a kinetic response is elicited from adherent macrophages in response to
individual planktonic C. albicans, we next assessed phagocyte migration in response to C. albicans that
had formed a biofilm. Typically, mature biofilms are composed of a network of yeast cells, hyphal
filaments, and extracellular material that has been secreted by the fungus. Therefore, 48 h biofilms of
C. albicans were pre-grown on imaging slides before the addition of J774.1 macrophages for 3D live
imaging and analysis of macrophage migration. Because pre-adhered macrophages could not be used
for experiments with Candida biofilms, the migration kinetics of macrophages added in suspension to
either biofilms or planktonic yeast were compared. As a further control, pre-adhered macrophages
responding to individual yeast were assessed. Imaging was conducted at 2 min intervals to permit
sufficient time for acquiring stacks of >60 focal planes in z (Figure 3).
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Figure 3. Representative single time point images acquired using Volocity software, showing J774.1
macrophages stained with LysoTracker Red (LTR; red), and C. albicans stained with Calcofluor White
(CFW; blue). Macrophages were added in suspension to (a) planktonic yeast (40× objective), or (b) and
(c) 48 h biofilms (20× objective); presented with (a) and (b) opacity 3D rendering, and (c) x, y and z at
20 µm depth. White grid unit or bar represents (a) 18.05 µm, (b) 36.17 µm, and (c) 40 µm.
Interactions were observed over a total of 30 min, with acquisition starting following a 45 min
period to allow macrophages in suspension to descend towards the fungal targets. Macrophage
migration was tracked in x- and y-axes using Volocity software. Within biofilms, migration of
phagocytes was analysed at a depth of 12–20 µm from the top of the biofilm. In response to planktonic
yeast, macrophages in suspension exhibited lower migratory activity, relative to adhered macrophages
(0.67 ± 0.08 SD; Figure 4). Within biofilms, macrophages added into suspension exhibited severely
impaired migration kinetics, relative to suspension macrophages in the presence of individual fungal
cells (0.75 ± 0.12 SD), or relative to adhered macrophages in the presence of yeast (0.50 ± 0.11 SD;
Figure 4). Therefore, the migration of macrophages was significantly impaired when moving through
a biofilm. This was not attributed to poor migration of suspension macrophages alone, because
suspension macrophages are stimulated to move significantly more in response to live fungi (Figure S4).
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kinetics of macroph ges within the biofilms. Biofilms of pmr1∆ were equal in thickness and no defect
in yphal growth was visible in comparison to both pmr1∆PMR1 a d CAI4 biofilms. The migration
kinetics of J774.1 macrophages within biofil s were d termined, as described abov . Although
individual C. albicans pmr1∆ cells in ced macrophage kinesis, macrophages within pmr1∆ biofilms
exhibited the same retarded migration as in control train biofilms (relative migration compared to
CAI4 or pmr1PMR1, respectively: 1.02± 0.38, 1.01± 0.07 SD; Figure 5). Therefore, the mannan-deficient
pmr1∆ biofilm did not nha ce the migration capacity of macrophages, or did planktonic pmr1∆ cells.
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Figure 5. Quantitative analysis of macrophage migration within 48 h biofilms prepared from C. albicans
strains CAI4, pmr1∆, and pmr1∆+PMR1. The chart shows mean relative macrophage velocity + SD
relative to macrophage velocity of J774.1 macrophages added in suspension to CAI4 (wild type
biofilms). Migration data over a 30 min period are shown. No statistical significance of mean
differences was determined using one-way analysis of variance (ANOV ) and Tukey Multiple Analysis
Comparison Tests.
4. Discussion
The fungal cell surface is subject to immunosurveillance by host innate immune cells, and can
be considered as a moving target, depending on the cues present at the site of Candida growth within
various human body niches [3–6]. It has been shown previously that fungal cell wall composition
affects phagocytosis of C. albicans by macrophages, with cell wall glycosylation mutants being engulfed
to either a lesser (e.g., mnn4∆ and pmr1∆) or greater extent (e.g., mnt1∆mnt2∆ and mns1∆) [22].
Stage-specific differences in the phagocytosis of C. albicans, and subsequent phagosome maturation,
have been investigated in finer detail using live cell imaging [10–12,21].
The present study expands our understanding of the effects of fungal cell wall composition on
macrophage migration in response to C. albicans. We show that macrophages tend to exhibit enhanced
migration towards all of the glycosylation mutants tested (mnt1∆mnt2∆, pmr1∆, mns1∆ and mnn4∆)
compared to wildtype. In all cases, migration was faster and the differences observed were greater
during the earliest stages of the experiment. Whether the reduction in macrophage migration over
the time course of the experiment was due to changing nutrient levels remains to be determined.
The enhanced macrophage migration in response to glycosylation mutants was not a consequence
of differences in maximum macrophage velocity, but of general enhanced movement. The most
marked difference was observed for migration towards the O-linked mannan-mutant mnt1∆mnt2∆,
confirming previous work [10]. An intermediate relative macrophage velocity was observed for
macrophages attracted towards the mnt1∆mnt2∆+MNT1 strain. While migration occurs in the initial
stage of phagocytosis, later stages also proceed at differential rates depending on the nature of the cell
wall, highlighting the importance of studying the different stages of phagocytosis separately [10,21,22].
Enhanced macrophage migration in response to C. albicans glycosylation cell wall mutants could be
a consequence of altered wall architecture, leading to exposure of pathogen-associated molecular
patterns (PAMPS) including β-glucan and chitin exposure [18], or alterations in cell wall protein
distributions. Altered cell wall charge may occur, particularly for the phosphomannan-deficient
strains (mnn4∆ and pmr1∆), which could generate charge interactions to which the macrophages
respond [19]. Enhanced secretion of chemoattractant molecules from C. albicans cell wall mutant
strains may result from altered wall architecture. It is also possible that the differences in migration
towards different cell wall mutants could be contact mediated if host cell filopodia were generated
that were too small to be resolved in the microscopical system used. Scanning electron microscopy
(SEM) images of macrophages co-cultured with C. albicans showed previously unseen macrophage
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membrane projections exceeding 40 µm [2]. Whether the presence of Candida with mutant cell walls
drives enhanced filopod extension remains to be determined.
Macrophages infiltrate tissue during pathogen clearance and tissue homeostasis, and are thus
professional migratory cells that transit within three-dimensional host tissue matrices of varying
densities. Amoeboid and mesenchymal migration motions are exhibited in loose and dense tissue
respectively [26]. Microbial biofilms represent an additional matrix in the host that can form on
indwelling catheters and prosthetic devices. Several features of biofilms preclude therapeutic resolution
and promote chronicity, including their recalcitrance to antifungal drug action, resistance to immune
cells, and metabolic plasticity [27]. In the present study, we prepared C. albicans biofilms in vitro for
48 h to permit substantial extracellular material to be extruded. We observed that biofilms impaired
the migration of macrophages by approximately 25% compared to macrophages that are added in
suspension to planktonic yeast. Adherent macrophages exhibited the greatest migratory activity in
response to planktonic yeast, thereby supporting the requirement for attachment to permit traction [26].
We observed that pmr1∆ planktonic yeast facilitated more rapid macrophage kinesis, but biofilms
formed from this strain did not. The pmr1∆ mutant was recently identified as able to trigger NETosis
by Candida biofilms, whereas wild type C. albicans biofilms block NET release [24]. The pmr1∆ mutant
forms a mature biofilm with a lower proportion of mannan in the extracellular matrix [25], and it is
the presence of a mannan-rich matrix which appears to block NETosis [24]. However, macrophage
migration is significantly impaired in both wild type and pmr1∆ biofilms. The factors that elicit
migration of macrophages in response to glycosylation mutants may not be expressed within a biofilm
as this growth form is characterised by differences in protein expression [28]. Secreted compounds
that may stimulate macrophage kinesis may also become sequestered in the extracellular matrix.
Although the precise mechanism of biofilm suppression of macrophage migration is unclear, these
findings support the hypothesis that biofilms are a further means by which pathogens evade host
immune responses. Biofilms suppress fungal damage by macrophages and neutrophils [24,29,30], and
may induce host responses that sustain their own growth [31]. A contiguous network of filaments
and material is likely to preclude complete phagocytic enclosure of the target. Such “frustrated
phagocytosis” may account for the impaired mobility of macrophages seen in Candida biofilms, both
directly (physical restriction) and indirectly (cytokine expression). Biofilms present a multifaceted
clinical problem, not only by providing a physical barrier against immune effectors or antifungal
drugs, and by acting as a reservoir for seeding further infection, but as described here, by hampering
phagocyte migration, thus restricting macrophage activity at such sites.
Supplementary Materials: The following are available online at www.mdpi.com/2309-608X/3/3/31/s1.
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